Biotech Analysts Agrawal, Chen & Watsek, along with Dr. Smith, Director of Genitourinary Malignancies Program at Massachusetts General Hospital, discuss novel therapies in prostate cancer on an Analyst/Industry conference call to be held on January 29 at 12 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EXEL:
- Bristol Myers, Exelixis announce four-year results from Opdivo-Cabometyx trial
- EPO rules in favor of Exelixis on patent covering Cabometyx
- Biotech Alert: Searches spiking for these stocks today
- Exelixis reports preliminary FY23 revenue $1.83B, consensus 1.84B
- Exelixis initiated with a Buy at BTIG
Questions or Comments about the article? Write to editor@tipranks.com